Discordantly high glycated hemoglobin might assist in diagnosing α‐thalassemia, but not diabetes: A case report

Abstract

Glycated hemoglobin (HbA1c) is an important method for monitoring blood glucose and diagnosing diabetes. High‐performance liquid chromatography is more commonly used in the laboratory for the detection of HbA1c. Although HbA1c detected by high‐performance liquid chromatography is susceptible to abnormal hemoglobin, there are few reports that it is affected by α‐thalassemia. Previous reports have generally concluded that α‐thalassemia does not affect or lower HbA1c. Here, we report a case of discordantly high HbA1c inconsistent with fasting blood glucose. Finally, the patient was diagnosed with α‐thalassemia and insulin resistance. α‐Thalassemia might lead to a discordantly high HbA1c result, which could be attributed to elevated hemoglobin H. In this case, glycated albumin might accurately reflect the real average level of blood glucose. When finding discordant HbA1c, patients should be advised to undergo thalassemia and hemoglobinopathy screening by diabetologists/endocrinologists or primary care physicians to avoid a missed diagnosis of hematopathy.

Correlation Between Blood Urea Nitrogen and Short- and Long-Term Glycemic Variability in Elderly Patients with Type 2 Diabetes Mellitus Who Were hospitalized:A Retrospective Study

“…While the monitoring of FPG levels is unaffected by these factors, laboratory testing of HbA1c levels can be impacted by anemia, chronic kidney disease, age, medication, race, and hemoglobin disorders. 34 They can only use HbA1c to represent the long-term GV of patients for 2–3 months. However, in this study, FPG were collected annually during the follow-up period to represent long-term GV.…”

Identification of DNA methylation of CAPN10 gene changes in the patients with type 2 diabetes mellitus as a predictive biomarker instead of HbA1c, random blood sugar, lipid profile, kidney function test, and some risk factors

“…Calculating HbA1c is crucial for blood glucose control. The American Diabetes Association has recognized HbA1c as a diagnostic standard for diabetes since 2010 (Gao et al 2022). HbA1c, a protein glycosylated form of hemoglobin, binds hemoglobin (Hb) in red blood cells to blood glucose.…”